Braveheart Bio, Inc. - Common Stock (NQ:BRVE)Price and VolumeDetailed Quote
Top NewsMore News
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
September 16, 2026
Performance
52-Week Range
33.9% below 52-week high
21.14
17.8652W Low
32.0052W High
1 Week
1.0% below 1-week high
18.001W Low
21.361W High
Braveheart Bio, Inc. - Common Stock (BRVE) traded between $17.86 and $32.00 over the past 52 weeks and last traded at $21.14, 33.9% below its 52-week high. Over the past week it ranged between $18.00 and $21.36.
Past 12 Months
1W
+$1.59
1M
-$3.88
3M
-$8.66
6M
-$8.66
YTD
-$8.66
1Y
-$8.66
BRVE was -29.0% over the past year, -29.0% over six months, -29.0% year to date, +8.2% in the last week.
12 Months vs Market
BRVE
DIA
SPY
QQQ
IWM
Over the past 12 months BRVE returned -29.0% versus DIA (Dow) +12.2%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +16.7% and IWM (Russell 2000) +11.6%.
Volume & Liquidity
0.00× 3-mo avg
Today 1,947
3-mo avg 513.3K
1W
1M
3M
6M
YTD
1Y
BRVE most recently traded 1,947 shares against a 3-month average daily volume of 513.3K. More NewsRead More
Braveheart Bio to Participate in Cantor Global Healthcare Conference
September 01, 2026
Insiders Are Betting Big on These 3 Healthcare Stocks ↗
August 31, 2026
Frequently Asked QuestionsIs Braveheart Bio, Inc. - Common Stock publicly traded?
Yes, Braveheart Bio, Inc. - Common Stock is publicly traded.
What exchange does Braveheart Bio, Inc. - Common Stock trade on?
Braveheart Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Braveheart Bio, Inc. - Common Stock?
The ticker symbol for Braveheart Bio, Inc. - Common Stock is BRVE on the Nasdaq Stock Market
What is the current price of Braveheart Bio, Inc. - Common Stock?
The current price of Braveheart Bio, Inc. - Common Stock is 21.14
When was Braveheart Bio, Inc. - Common Stock last traded?
The last trade of Braveheart Bio, Inc. - Common Stock was at 10/22/26 09:44 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|